Immuno-Oncology Essentials: An Overview

Abstract

© 2019 HarborsideTM We are honored to share with you this supplement entitled ImmunoOncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events. Immunotherapy with immune checkpoint inhibitors (ICIs) has remarkably revolutionized cancer care, improving outcomes for many patients with diverse tumor types. The awarding of the 2018 Nobel Prize in Medicine to two of the scientists involved with ICI development, James P. Allison and Tasuku Honjo, is a testament to this fact. The impact of ICIs is likely to continue to expand, as these therapies are used in an ever-growing